Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
510
NCT02749825
Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
Phase: Phase 4
Role: Lead Sponsor
Start: Sep 30, 2002
Completion: Jul 31, 2006
NCT00496873
Evaluation of the Safety and Efficacy of Nipent, Cytoxan, and Rituxan
Phase: Phase 2
Role: Collaborator
Start: Jun 30, 2005
Completion: Dec 31, 2014
NCT00766246
Phase II Avastin Trial for Stage IIIB/IV NSCLC
Start: Oct 31, 2008
Completion: Apr 30, 2012
NCT00831597
Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Start: Nov 30, 2008
Completion: Sep 30, 2013
NCT02749838
Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens
Phase: N/A
Start: May 31, 2014
Completion: Dec 31, 2017